RHYTHM PHARMACEUTICALS, INC. (RYTM) › Capital ExpendituresRHYTHM PHARMACEUTICALS, INC. (RYTM) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2015: $17.0K2016: $1.06M2017: $133.0K2018: $722.0K2019: $3.38M2020: $214.0K2021: $434.0K2022: $281.0K2023: $47.0K2024: $02025: $953.0K$953.0K2015Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$953.0K—2024$0-100.0%2023$47.0K-83.3%2022$281.0K-35.3%2021$434.0K+102.8%2020$214.0K-93.7%2019$3.38M+368.8%2018$722.0K+442.9%2017$133.0K-87.4%2016$1.06M+6117.6%2015$17.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share